Nuclear Medicine
AMMONIUM
Name:
Myocardiopet Radiofarma
Active Principle:
13N-Ammonium Chloride
Therapeutic Action:
It is indicated for the evaluation of myocardial perfusion in patients with suspected or existing coronary artery disease. It allows calculating the coronary reserve, diagnosing infective endocarditis, vasculitis, cardiac sarcoidosis and infection in pacemaker implants.
Nuclear Medicine
AMMONIUM
Name:
Myocardiopet Radiofarma
Active Principle:
13N-Ammonium Chloride
Therapeutic Action:
It is indicated for the evaluation of myocardial perfusion in patients with suspected or existing coronary artery disease. It allows calculating the coronary reserve, diagnosing infective endocarditis, vasculitis, cardiac sarcoidosis and infection in pacemaker implants.
RELATED PRODUCTS
-
IODOSOL 123I (R&D)
IODOSOL 123I (R&D)Sodium iodide (123I) solution is indicated as a diagnostic agent to evaluate thyroid function and/or morphology by scintigraphy and radioactive iodine uptake test. -
131I MIBG BACON (R&D)
131I MIBG BACON (R&D)It is indicated for the diagnosis and location of neuroendocrine tumors, pheochromocytoma, medullary thyroid cancer, primary neuroblastomas and their metastases, paragangliomas and thymomas... -
FLPET (R+D)
FLPET (R+D)It is indicated for the detection and evaluation of cell proliferation in lung, breast, colorectal, melanoma, soft tissue sarcoma and primary or metastatic brain tumors. It allows to predict the aggressiveness...